FI870644A - Foerfarande foer framstaellning av en makromolekylbaerare belastad med biologiskt aktivt aemne. - Google Patents

Foerfarande foer framstaellning av en makromolekylbaerare belastad med biologiskt aktivt aemne. Download PDF

Info

Publication number
FI870644A
FI870644A FI870644A FI870644A FI870644A FI 870644 A FI870644 A FI 870644A FI 870644 A FI870644 A FI 870644A FI 870644 A FI870644 A FI 870644A FI 870644 A FI870644 A FI 870644A
Authority
FI
Finland
Prior art keywords
ldl
pct
active substance
biologically active
lyophilized
Prior art date
Application number
FI870644A
Other languages
English (en)
Other versions
FI86802B (fi
FI870644A0 (fi
FI86802C (fi
Inventor
Michele Masquelier
Curt Peterson
Mikael Ros
Mats Rudling
Sigurd Vitols
Original Assignee
Oncholab Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncholab Ab filed Critical Oncholab Ab
Publication of FI870644A publication Critical patent/FI870644A/fi
Publication of FI870644A0 publication Critical patent/FI870644A0/fi
Publication of FI86802B publication Critical patent/FI86802B/fi
Application granted granted Critical
Publication of FI86802C publication Critical patent/FI86802C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1275—Lipoproteins; Chylomicrons; Artificial HDL, LDL, VLDL, protein-free species thereof; Precursors thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
FI870644A 1985-06-17 1987-02-16 Foerfarande foer framstaellning av en makromolekylbaerare belastad med biologiskt aktivt aemne FI86802C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE8502998A SE456136B (sv) 1985-06-17 1985-06-17 Forfarande for framstellning av en med ett lipofilt biologiskt aktivt emne bemengd berare pa basis av rekonstituerat ldl (lagdensitetslipoprotein)
SE8502998 1985-06-17
SE8600291 1986-06-17
PCT/SE1986/000291 WO1986007540A1 (en) 1985-06-17 1986-06-17 Method for the preparation of a macromolecular carrier loaded with a biologically active substance, product thus obtained and use thereof

Publications (4)

Publication Number Publication Date
FI870644A true FI870644A (fi) 1987-02-16
FI870644A0 FI870644A0 (fi) 1987-02-16
FI86802B FI86802B (fi) 1992-07-15
FI86802C FI86802C (fi) 1992-10-26

Family

ID=20360603

Family Applications (1)

Application Number Title Priority Date Filing Date
FI870644A FI86802C (fi) 1985-06-17 1987-02-16 Foerfarande foer framstaellning av en makromolekylbaerare belastad med biologiskt aktivt aemne

Country Status (11)

Country Link
US (1) US4868158A (fi)
EP (1) EP0229100B1 (fi)
JP (1) JPS62502549A (fi)
AT (1) ATE67412T1 (fi)
AU (1) AU583402B2 (fi)
DE (1) DE3681578D1 (fi)
DK (1) DK168785B1 (fi)
FI (1) FI86802C (fi)
NO (1) NO169048C (fi)
SE (1) SE456136B (fi)
WO (1) WO1986007540A1 (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2609399A1 (fr) * 1987-01-13 1988-07-15 Ire Celltarg Sa Procede d'incorporation d'un ou plusieurs principes actifs lipophiles dans des lipoproteines, lipoproteines obtenues et composition pharmaceutique les contenant
FR2664500B1 (fr) * 1990-07-13 1994-10-28 Lille Ii Universite Droit Sant Procede de preparation d'une lipoproteine modifiee par incorporation d'une substance active lipophile, lipoproteine modifiee ainsi obtenue et composition pharmaceutique ou cosmetique la contenant.
WO1993008842A1 (en) * 1991-11-08 1993-05-13 Somatogen, Inc. Hemoglobins as drug delivery agents
AU3892593A (en) * 1992-04-08 1993-11-18 Paavo Kai Johannes Kinnunen Composition for therapeutic or diagnostic use, process for its preparation and its use
NZ275054A (en) * 1993-11-08 1997-04-24 Peptide Delivery Systems Pty L Diagnosing atherosclerosis or coronary artery disease using labelled composition which mimics essential features of an exogenous lipoprotein
AU690592B2 (en) * 1993-11-08 1998-04-30 Peptide Delivery Systems Pty Ltd Labelled diagnostic compositions and methods of their use
US5652339A (en) * 1993-12-31 1997-07-29 Rotkreuzstiftung Zentrallaboratorium Method of producing reconstituted lipoproteins
US6610321B2 (en) 1996-07-03 2003-08-26 University Of Pittsburgh Emulsion formulations for hydrophilic active agents
AUPP032097A0 (en) * 1997-11-11 1997-12-04 Peptide Delivery Systems Pty Ltd Improved labelled diagnostic compositions and methods of their use
US6514523B1 (en) 2000-02-14 2003-02-04 Ottawa Heart Institute Research Corporation Carrier particles for drug delivery and process for preparation
US20090110739A1 (en) * 2007-05-15 2009-04-30 University Of North Texas Health Science Center At Forth Worth Targeted cancer chemotherapy using synthetic nanoparticles
WO2010057203A2 (en) 2008-11-17 2010-05-20 The Board Of Regents Of The University Of Texas System Hdl particles for delivery of nucleic acids
US20160346219A1 (en) 2015-06-01 2016-12-01 Autotelic Llc Phospholipid-coated therapeutic agent nanoparticles and related methods
FI20215508A1 (fi) 2020-04-09 2021-10-10 Niemelae Erik Johan Mimeettisiä nanopartikkeleita uusien koronavirusten leviämisen estämiseksi ja infektioasteen alentamiseksi

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ180199A (en) * 1976-03-04 1978-11-13 New Zealand Dev Finance Method of testing for the presence of elevated plasma liprotein concentration
US4186192A (en) * 1978-12-18 1980-01-29 Cutter Laboratories, Inc. Stabilized immune serum globulin
US4440679A (en) * 1980-03-05 1984-04-03 Cutter Laboratories, Inc. Pasteurized therapeutically active protein compositions
US4356117A (en) * 1980-10-23 1982-10-26 U.S. Govt., Dept. Of Health & Human Services Chemical modifications of proteins which induce new receptor specificities and therefore elicit new effects in cells
JPS5967228A (ja) * 1982-10-07 1984-04-16 Green Cross Corp:The 寒冷不溶性グロブリンの凍結乾燥方法
US4478829A (en) * 1983-04-28 1984-10-23 Armour Pharmaceutical Company Pharmaceutical preparation containing purified fibronectin
NZ208241A (en) * 1984-05-22 1987-09-30 John Stephen Ayers Purification of blood plasma or serum: selective removal of (very) low density lipoproteins (ldl and vldl)
EP0238645A1 (en) * 1985-10-03 1987-09-30 Biotechnology Research Partners, Ltd. Novel lipoprotein-based drug-delivery systems

Also Published As

Publication number Publication date
US4868158A (en) 1989-09-19
NO169048B (no) 1992-01-27
AU583402B2 (en) 1989-04-27
SE8502998L (sv) 1986-12-18
WO1986007540A1 (en) 1986-12-31
JPS62502549A (ja) 1987-10-01
FI86802B (fi) 1992-07-15
EP0229100B1 (en) 1991-09-18
FI870644A0 (fi) 1987-02-16
SE456136B (sv) 1988-09-12
NO169048C (no) 1992-05-06
NO870545D0 (no) 1987-02-11
JPH0586935B2 (fi) 1993-12-14
FI86802C (fi) 1992-10-26
NO870545L (no) 1987-02-11
AU5996886A (en) 1987-01-13
ATE67412T1 (de) 1991-10-15
DK168785B1 (da) 1994-06-13
DE3681578D1 (de) 1991-10-24
DK77787D0 (da) 1987-02-16
DK77787A (da) 1987-02-16
SE8502998D0 (sv) 1985-06-17
EP0229100A1 (en) 1987-07-22

Similar Documents

Publication Publication Date Title
FI870644A (fi) Foerfarande foer framstaellning av en makromolekylbaerare belastad med biologiskt aktivt aemne.
Singh et al. Regulation of gonadal steroidogenesis in Fundulus heteroclitus by recombinant salmon growth hormone and purified salmon prolactin
Kandutsch et al. Studies on a substance that promotes tumor homograft survival (the" enhancing substance"): Its distribution and some properties
Kirby A new method for the isolation of ribonucleic acids from mammalian tissues
CRONIN et al. Human pancreatic tumor growth hormone (GH)-releasing factor and cyclic adenosine 3′, 5′-monophosphate evoke GH release from anterior pituitary cells: the effects of pertussis toxin, cholera toxin, forskolin, and cycloheximide
CHAKRAVARTY et al. Mechanism of tho Release by Componnd 48/80 of Histamine and of a Lipid‐Soluble Smooth Muscle Stimulating Principle (“SRS”)
Lichtenberger et al. Importance of amino acid uptake and decarboxylation in gastrin release from isolated G cells
Fell The role of organ cultures in the study of vitamins and hormones
Haller et al. Alcoholic rhabdomyolysis: an experimental model in the rat
Gottschalk Neuraminic acid: the functional group of some biologically active mucoproteins
Jenkins A morphological and histochemical study of Trichuris suis (Schrank, 1788) with special reference to the host-parasite relationship
FR2466250A1 (fr) Medicament anticoccidien, et procede de vaccination des volailles avec ce medicament
Louw et al. Action of thyrocalcitonin in the teleost fish Ictalurus melas
Catt et al. Cyclic AMP released by rat testis during gonadotrophin stimulation in vitro
White Effects of steroids on aspects of the metabolism and functions of the lymphocyte: a hypothesis of the cellular mechanisms in antibody formation and related immune phenomena
SE8703064D0 (sv) Method for isolating active enzyme preparations from animal tissues
Badawy et al. Changes in liver tryptophan and tryptophan pyrrolase activity after administration of salicylate and tryptophan to the rat
Kempen et al. Rat pancreatic adenylate cyclase: IV. Effect of hormones and other agents on cyclic AMP level and enzyme release
FI912687A0 (fi) Araban fraon vilken foergreningar avlaegsnats och dess anvaendning som fettersaettare.
Nicholas The biology of the Acanthocephala
Strang et al. Extraction, purification and turnover of rat brain glycogen
KYRIAKOU et al. Lactogenesis in the diabetic rat
WENDEL et al. A cytochemical approach to the lipid composition of mitochondrial matrix granules in brown adipose tissue and liver
Fingerman et al. The role of cations in the actions of the hormones controlling the red chromatophores of the prawn, Palaemonetes vulgaris
Nagata et al. Inhibition by cholera toxin of parathyroid hormone-induced calcium release from bone in culture

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: ONCHOLAB AB